| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 34,690 | 37,819 | 49,759 | 58,620 | | Cost of Revenue | 25,936 | 28,665 | 34,431 | 41,561 | | | Gross Profit | 8,754 | 9,154 | 15,328 | 17,059 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,961 | 4,883 | 5,850 | 6,714 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,293 | 1,233 | 1,183 | 1,194 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,500 | 3,038 | 8,295 | 9,151 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (593) | 230 | (52) | 170 | | Earnings Before Interest And Taxes | 1,998 | 3,396 | 8,194 | 9,325 | | Interest Expense | 752 | 867 | 902 | 1,269 | | Income Before Tax | 1,246 | 2,529 | 7,292 | 8,056 | | Income Tax Expense | 151 | 1,013 | 2,376 | 2,671 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,095 | 1,516 | 4,916 | 5,385 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,095 | 1,516 | 4,916 | 5,385 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,095 | $1,516 | $4,916 | $5,385 |
|
0.51% Nasdaq 
Income Statement
